Upload
jaime-bryant
View
52
Download
0
Tags:
Embed Size (px)
DESCRIPTION
Drug Addiction & Risky Business. June 30, 2011. Prospect Gambling Experiment. http://myweb.fsu.edu/djcooper/teaching/prospect.pdf. Prospect Gambling. - PowerPoint PPT Presentation
Citation preview
Prospect Gambling Prospect Gambling ExperimentExperiment
http://myweb.fsu.edu/djcooper/teaching/prospect.pdf
Prospect GamblingProspect Gambling
For each pair, you will be asked to choose For each pair, you will be asked to choose one of the two gambles. You should record one of the two gambles. You should record your choice on a sheet of paper by writing your choice on a sheet of paper by writing either Gamble A or Gamble B for each pair. either Gamble A or Gamble B for each pair.
Some of the gambles will have negative Some of the gambles will have negative payoffs. The maximum amount you can lose payoffs. The maximum amount you can lose is $4. is $4.
ImpulsivityImpulsivity Predisposition toward rapid, unplanned Predisposition toward rapid, unplanned
reactions to stimuli without regard to reactions to stimuli without regard to negative consequencesnegative consequences
Best understood through examining Best understood through examining disorders associated with impulsivitydisorders associated with impulsivity
Impulse-Control DisordersImpulse-Control Disorders– Seeking a small, short-term gain at the Seeking a small, short-term gain at the
expensive of a large, long-term lossexpensive of a large, long-term loss– IED, pathological gambling, trichotillomania, IED, pathological gambling, trichotillomania,
kleptomaniakleptomania Seems to be associated with serotoninSeems to be associated with serotonin
SerotoninSerotonin Low levels of serotonin metabolites Low levels of serotonin metabolites
correlate with risk-takingcorrelate with risk-taking Vervet monkeys given 5-HT agonist: Vervet monkeys given 5-HT agonist:
become dominantbecome dominant 5-HT 1B KO mice are quicker to 5-HT 1B KO mice are quicker to
attack opponentattack opponent 5-HT controls risk taking, which 5-HT controls risk taking, which
impacts aggressive behaviorimpacts aggressive behavior
Risk-Taking & The BrainRisk-Taking & The Brain
People who seek risks can be thought of as People who seek risks can be thought of as “reducers”: Their brains reduce the level “reducers”: Their brains reduce the level of incoming stimuli, thus decreasing their of incoming stimuli, thus decreasing their excitementexcitement
Monoamine Oxidase (MAO) plays a role in Monoamine Oxidase (MAO) plays a role in this: Low levels of MAO are associated this: Low levels of MAO are associated with high risk-takingwith high risk-taking
MAO regulates levels of:MAO regulates levels of:– Norepinephrine (arousal)Norepinephrine (arousal)– Dopamine (pleasure & reward)Dopamine (pleasure & reward)– Serotonin (inhibits arousal)Serotonin (inhibits arousal)
High risk-takers may have decreased High risk-takers may have decreased levels of norepinephrine and dopaminelevels of norepinephrine and dopamine
Impulsivity AssessmentImpulsivity Assessment
1.1. I like to keep moving I like to keep moving 2.2. I make friends easily I make friends easily 3.3. I like lots of physical activityI like lots of physical activity4.4. I feel a lot of tensionI feel a lot of tension5.5. I talk more than the I talk more than the
average personaverage person6.6. I enjoy lots of I enjoy lots of
environmental stimulation environmental stimulation (excitement, activity)(excitement, activity)
7.7. My home life is not always My home life is not always happyhappy
8.8. When things get quiet, I like When things get quiet, I like to stir things up to stir things up
9.9. I am usually restless I am usually restless 10.10. I don’t think I’m as happy I don’t think I’m as happy
as other peopleas other people
11.11. I get angry oftenI get angry often12.12. I like being the center of I like being the center of
attention at social gatheringsattention at social gatherings13.13. I feel very anxious if I cannot I feel very anxious if I cannot
find a release for my anger find a release for my anger 14.14. It’s hard for me to stick with It’s hard for me to stick with
various projects at work and various projects at work and homehome
15.15. I will fight with someone, even I will fight with someone, even if I know I am wrongif I know I am wrong
16.16. I’m not known as a hard and I’m not known as a hard and steady workersteady worker
17.17. I feel relief after I release my I feel relief after I release my anger through some avenueanger through some avenue
18.18. Sometimes I act impulsivelySometimes I act impulsively19.19. I find it difficult to relax and I find it difficult to relax and
unwind unwind 20.20. I live with many regrets from I live with many regrets from
past actionspast actions
Used with permission of Paul Hirshfield, Hirshfield and Associates, 529 Pharr Road, Atlanta, Georgia 30305http://www.roberts.edu/LifeAtRoberts/ResidentLife/counselingCenter/Documents/Impulsivity%20Assessment.pdf
Dopamine Pathways
Functions•reward (motivation)•pleasure,euphoria•motor function (fine tuning)•compulsion•perserveration•decision making
Serotonin PathwaysFunctions•mood•memory processing•sleep•cognition
nucleusaccumbens
hippocampus
striatum
frontalcortex
substantianigra/VTA
raphe
From Lecture by Glen R. Hanson, NIDA
nucleusaccumbens
hippocampus
striatum
frontalcortex
substantianigra/VTA
raphe
nucleusaccumbens
hippocampus
striatum
frontalcortex
substantianigra/VTA
raphe
Dopamine-containing neurons are the pleasure generating cells of the brain From Lecture by Glen R. Hanson, NIDA
/serotonin/serotonin
Vmat
transporterstimulationstimulation
DA/5HT DA/5HT
How some drugs of abuse cause dopamine release:• opioids narcotics (activate opioid receptors)• nicotine (activate nicotine receptors)• marijuana (activate cannabinoid receptors)• caffeine• alcohol (activate GABA receptors; an inhibitory transmitter)
How some drugs of abuse cause dopamine release:• opioids narcotics (activate opioid receptors)• nicotine (activate nicotine receptors)• marijuana (activate cannabinoid receptors)• caffeine• alcohol (activate GABA receptors; an inhibitory transmitter)
Drug :• cocaine• ritalin
vesicle Neuronal terminal
From Lecture by Glen R. Hanson, NIDA
• Release DA from vesicles and reverse transporter
Drug Types:• Amphetamines -methamphetamine -MDMA (Ecstasy)
Vmat
transporter
serotonin/serotonin/
DA/5HT DA/5HT
From Lecture by Glen R. Hanson, NIDA
00100100200200300300400400500500600600700700800800900900
1000100011001100
00 11 22 33 44 5 hr5 hr
Time After AmphetamineTime After Amphetamine
% o
f B
as
al
Re
lea
se
% o
f B
as
al
Re
lea
se
DADADOPACDOPACHVAHVA
AccumbensAccumbens AMPHETAMINEAMPHETAMINE
00
100100
200200
300300
400400
00 11 22 33 44 5 hr5 hrTime After CocaineTime After Cocaine
% o
f B
as
al
Re
lea
se
% o
f B
as
al
Re
lea
se
DADADOPACDOPACHVAHVA
AccumbensAccumbensCOCAINECOCAINE
00
100100
150150
200200
250250
00 11 22 3 hr3 hr
Time After NicotineTime After Nicotine
% o
f B
as
al
Re
lea
se
% o
f B
as
al
Re
lea
se
AccumbensAccumbensCaudateCaudate
NICOTINENICOTINE
Source: Di Chiara and ImperatoSource: Di Chiara and Imperato
Effects of Drugs on Dopamine ReleaseEffects of Drugs on Dopamine ReleaseEffects of Drugs on Dopamine ReleaseEffects of Drugs on Dopamine Release
100100
150150
200200
250250
00 11 22 33 4hr4hrTime After EthanolTime After Ethanol
% o
f B
as
al
Re
lea
se
% o
f B
as
al
Re
lea
se
0.250.250.50.5112.52.5
AccumbensAccumbens
00
Dose (g/kg ip)Dose (g/kg ip)
ETHANOLETHANOLETHANOLETHANOL
Much greaterActivity than anyOther drug of abuse -causes neurotoxicity
From Lecture by Glen R. Hanson, NIDA
CRITERIA FOR SUBSTANCE CRITERIA FOR SUBSTANCE ABUSEABUSE
A. A maladaptive pattern of substance use leading to clinically significant impairment or distress, as manifested by one (or more) of the following, occurring within a 12-month period:
1. recurrent substance use resulting in a failure to fulfill major role obligations at work, school, or home (e.g., repeated absences or poor work performance related to substance use; substance-related absence, suspensions, or expulsions from school; neglect of children or household);2. recurrent substance use in situations in which it is physically hazardous (e.g., driving an automobile or operating a machine when impaired by substance use);3. recurrent substance-related legal problems (e.g., arrests for substance- related disorderly conduct);4. continued substance use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of the substance (e.g., arguments with spouse about consequences of
intoxication, physical fights).
B. The symptoms have never met the criteria for Substance Dependence for this class of substance.
From Lecture by Leonard Howell, Emory University
Volkow et al. Am. J. Psychiatry 148, 621Volkow et al. Am. J. Psychiatry 148, 621
control cocaine abuser
Decreases in Metabolism in Orbito Frontal Cortex (OFC)
From Lecture by Glen R. Hanson, NIDA
Source: McCann U.D. et al., The Journal of Neuroscience, 18(20), pp. 8417-8422, October 15, 1998.Source: McCann U.D. et al., The Journal of Neuroscience, 18(20), pp. 8417-8422, October 15, 1998.
(note: duration of use/3-20 yrs; abstinent/ 1-4 yrs)
METH Suppresses Expression of DAT
From Lecture by Glen R. Hanson, NIDA
Comparison Subject METH AbuserComparison Subject METH Abuser
Source: Volkow, N.D. et al., Am J. Psychiatry, 158(3), pp. 377-382, 2001. Source: Volkow, N.D. et al., Am J. Psychiatry, 158(3), pp. 377-382, 2001.
Dopamine Transporter Loss After
Heavy Methamphetamine Use
From Lecture by Glen R. Hanson, NIDA
Following Drug AddictionFollowing Drug Addiction
Ability to experience rewards is impaired.Ability to experience rewards is impaired. Commonalities in underlying Commonalities in underlying
neurobiological forces can often lead to neurobiological forces can often lead to co-morbid conditions.co-morbid conditions.– GeneticGenetic– Structural/AnatomicalStructural/Anatomical– NeurochemicalNeurochemical
Because of this overlap, drugs of abuse Because of this overlap, drugs of abuse can cause symptoms that mimic most can cause symptoms that mimic most forms of mental illness.forms of mental illness.
From Lecture by Glen R. Hanson, NIDA
CommonalitiesCommonalities
Cocaine and Methamphetamine
Schizophrenia, paranoia,anhedonia, compulsivebehavior
Stimulants Anxiety, panic attacks, mania and sleep disorders
LSD, Ecstasy & psychedelics Delusions and hallucinations
Alcohol, sedatives, sleepaids & narcotics
Depression and mood disturbances
PCP & Ketamine Antisocial behavior
From Lecture by Glen R. Hanson, NIDA
System Hijack!System Hijack!
Drugs of AbuseDrugs of Abuse
http://learn.genetics.utah.edu/content/addiction/drugs/mouse.html
Common Drugs of AbuseCommon Drugs of Abuse
CocaineCocaine Dopamine, Serotonin, Dopamine, Serotonin, NorepinephrineNorepinephrine
MethamphetamiMethamphetaminene
DopamineDopamine
LSDLSD SerotoninSerotonin
AlcoholAlcohol Dopamine, GABA, Serotonin, Dopamine, GABA, Serotonin, Acetylcholine, Glutamate Acetylcholine, Glutamate
HeroinHeroin GABA, Opiate ReceptorsGABA, Opiate Receptors
MarijuanaMarijuana Cannabinoid ReceptorsCannabinoid Receptors
EcstacyEcstacy Serotonin, weaker effects on Serotonin, weaker effects on Dopamine and NorepinephrineDopamine and Norepinephrine
Rodent Rodent Self-AdministrationSelf-Administration
http://science-education.nih.gov/supplements/nih2/Addiction/guide/pdfs/nih_drug.pdf
David Weinshenker, PhDDavid Weinshenker, PhD
Emory UniversityEmory University
Current ResearchCurrent Research